Education
About Us
Working with TipRanks
Follow Us
Molecule Holdings (TSE:MLCL)
:MLCL
Total Valuation
Molecule Holdings has a market cap or net worth of C$488.91K. The enterprise value is ―.
Market CapC$488.91K
Enterprise Value―
Share Statistics
Molecule Holdings has 97,781,906 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding97,781,906
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Molecule Holdings’s return on equity (ROE) is 1.23 and return on invested capital (ROIC) is -250.72%.
Return on Equity (ROE)1.23
Return on Assets (ROA)-1.16
Return on Invested Capital (ROIC)-250.72%
Return on Capital Employed (ROCE)1.08
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.50
Inventory Turnover5.01
Valuation Ratios
The current PE Ratio of Molecule Holdings is ―. Molecule Holdings’s PEG ratio is 0.08.
PE Ratio―
PS Ratio2.22
PB Ratio-1.18
Price to Fair Value-1.18
Price to FCF-3.76
Price to Operating Cash Flow-0.43
PEG Ratio0.08
Income Statement
In the last 12 months, Molecule Holdings had revenue of 1.97M and earned -4.54M in profits. Earnings per share was -0.05.
Revenue1.97M
Gross Profit-1.07M
Operating Income-3.91M
Pretax Income-4.54M
Net Income-4.54M
EBITDA-3.87M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -98.67K and capital expenditures 0.00, giving a free cash flow of -98.67K billion.
Operating Cash Flow-98.67K
Free Cash Flow-98.67K
Free Cash Flow per Share>-0.01
Dividends & Yields
Molecule Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.22
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)10.06K
Important Dates
Molecule Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Molecule Holdings as a current ratio of 0.17, with Debt / Equity ratio of -140.63%
Current Ratio0.17
Quick Ratio0.09
Debt to Market Cap1.17
Net Debt to EBITDA-1.32
Interest Coverage Ratio-6.17
Taxes
In the past 12 months, Molecule Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Molecule Holdings EV to EBITDA ratio is -2.45, with an EV/FCF ratio of -8.16.
EV to Sales4.82
EV to EBITDA-2.45
EV to Free Cash Flow-8.16
EV to Operating Cash Flow-8.40
Balance Sheet
Molecule Holdings has C$141.93K in cash and marketable securities with C$5.83M in debt, giving a net cash position of -C$5.69M billion.
Cash & Marketable SecuritiesC$141.93K
Total DebtC$5.83M
Net Cash-C$5.69M
Net Cash Per Share-C$0.06
Tangible Book Value Per Share-C$0.04
Margins
Gross margin is -54.56%, with operating margin of -198.86%, and net profit margin of -230.84%.
Gross Margin-54.56%
Operating Margin-198.86%
Pretax Margin-230.84%
Net Profit Margin-230.84%
EBITDA Margin-196.57%
EBIT Margin-198.59%
Analyst Forecast
The average price target for Molecule Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―